Cover Image
市場調查報告書

MediPoint:電力生理檢驗 - 全球市場的分析與預測

MediPoint: Electrophysiology - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 296804
出版日期 內容資訊 英文 368 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:電力生理檢驗 - 全球市場的分析與預測 MediPoint: Electrophysiology - Global Analysis and Market Forecasts
出版日期: 2014年03月01日 內容資訊: 英文 368 Pages
簡介

電力生理(EP)檢查裝置市場,還初期是階段,不過,多的醫生隨著積累診斷和切除技術的經驗,完成著大幅度的採用與市場成長。補助設備購買後的醫院數也增加,設備價格也下降,有效性也提高著。

本報告提供全球電力生理檢查裝置市場相關調查分析、產業概要、市場區隔分析、市場預測、競爭評估、開發中產品相關驗證,再加上主要企業簡介、交易分析等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 簡介
  • 解剖生理學
  • 臨床表現
  • 診斷
  • 流行病學
  • 市場區隔
  • 治療成本、價格設定、給付制度
  • 市場特徵
  • 法規的問題/回收

第4章 市場區隔分析

  • 切除治療用導管
  • 診斷導管
  • 實驗室系統

第5章 市場預測:市場部門別

  • 全球切除治療用導管市場

第6章 市場預測:各地區

  • 美國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 英國
  • 日本
  • 中國
  • 印度
  • 巴西

第7章 策略性競爭評估

  • 主要企業的市場佔有率

第8章 現在/未來的主要企業

  • 概要、投資組合、SWOT分析等
    • Biosense Webster
    • Biotronik
    • Boston Scientific
    • CardioFocus
    • CardioInsight
    • Hansen Medical
    • Imricor
    • 日本life line
    • Magnetecs Corporation
    • Medtronic
    • MicroPort Scientific Company
    • St. Jude Medical
    • Stereotaxis
    • Stryker Sustainability Solutions
    • Topera Medical

第9章 開發中產品的評估

  • 各發展階段
  • 市場區隔分析
  • 實驗室系統

第10章 策略性交易分析

  • 主要的收購
  • 主要的夥伴關係

第11章 附錄

圖表

目錄
Product Code: GDME0205MAR

Still in its infancy, the electrophysiology (EP) device market has seen significant adoption and market growth as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device prices fall, and efficacy improves. This continued growth is also driven by technological advancements, including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Still years behind the US, growth in emerging markets is also expected to drive sales, as developing countries look to implement new EP programs and hospitals adopt ablation techniques. Increases in the prevalence of arrhythmia, combined with improved diagnostics and patient awareness, are expected to support industry expansion. Lastly, published studies, clinical evidence and patient awareness will all contribute positively to EP market growth, and will provide further evidence of the effectiveness of catheter ablation.

The EP market is dominated by several key players, including Biosense Webster, St. Jude Medical, Boston Scientific, Medtronic and Biotronik, with the biggest markets in the US and EU. With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals than ever, and this is only expected to increase. With only a few key players in the market currently, competition remains high, as industry leaders fight for valuable market share.

GlobalData has released its medical device report, Electrophysiology - Global Analysis and Market Forecasts. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report provides insight into the competitive EP landscape, including new companies approaching commercialization and pipeline products in development. It quantifies the potential of rising use of advanced ablation and diagnostic catheters, as well as examines the impact of next-generation mapping and navigation technology on patient outcomes. Included in the report is investigation of the highest growth sectors for EP, with a focus on next-generation technologies due to enter the market, including laser energy and three-dimensional mapping technology. This report was built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of cardiovascular medical device experts.

Highlights

Key Questions Answered

  • Improvements in EP device technology are evident in improved patient outcomes. (Q). How have clinical trials touting patient benefits shaped the EP device landscape? (Q). How will they affect adoption?
  • Cardiac ablation is increasingly used as a first-line therapy in lieu of AADs. (Q). What is to be expected in terms of regulation and reimbursement around the use of ablation over AADs? (Q). How will AADs be used as adjunctive therapy in the future?
  • Technological advancements have enabled next-generation therapy, including irrigated catheters and alternative energy ablation tools. (Q). What technologies will be most popular in the coming years? (Q). What products are positioned to see significant adoption?
  • The EP devices market in the developing countries of the Asia-Pacific region as well as South America is expected to experience higher rates of growth compared with the US and EU. (Q). Which countries will have the highest annual growth rate in the EP diagnostic catheter, ablation catheter and lab systems markets?
  • As more hospitals look to implement EP operations, lab systems sales are on the rise as a result. (Q). How many hospitals are there in each country, and how many are looking to implement EP? How is this changing during the forecast period?

Key Benefits

"What Do Physicians Think?" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision-makers in every organization, allowing them to act on high-quality information.

Scope

  • An overview of arrhythmia, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines worldwide
  • Annualized global EP device market revenue, future forecasts and procedure patterns data from 2005 and forecast to 2020, including use of standard and advanced diagnostic and ablation catheters, as well as lab systems
  • Investigation of current and future market competition for EP devices
  • Coverage of ten major markets, including the United States, the United Kingdom, Italy, Spain, Germany, France, Japan, China, India and Brazil
  • Insightful review of the key industry drivers, restraints and challenges, as well as predicted impact of future key events
  • Competitive assessment with device approval analysis and sales forecasts
  • Marketed and pipeline product profiles covering efficacy, safety, clinical study details, regulatory approvals, and forecast device sales
  • Analysis of unmet needs within the market and opportunities for future players
  • Evaluation of technology trends to assess pipeline product strength
  • Overview of all devices in development, including clinical study details, design considerations, efficacy reports, and device approval timelines
  • Coverage of key market players with portfolio assessment and SWOT analysis
  • Strategic assessment of the device sector through market impact, future market scenario and company analysis
  • Direct quotes from Key Opinion Leaders (KOL) currently using EP devices

Reasons to buy

  • Understand the trends shaping and driving the ablation catheter, diagnostic catheter and lab system markets
  • Realize device preferences of physicians who have performed hundreds of catheter diagnostic and ablation procedures already
  • Access market sizing, forecasts and quantified growth opportunities in the global EP market through 2020
  • Quantify candidate patient populations worldwide to better design product pricing and launch plans
  • Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape
  • Perform benchmarking analysis of growth opportunities against currently marketed products
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth
  • What's the next big thing in the global EP market landscape? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Introduction
  • 3.2. Anatomy and Physiology
    • 3.2.1. Etiology
    • 3.2.2. Risk Factors
    • 3.2.3. Types of Arrhythmia
  • 3.3. Clinical Presentation
    • 3.3.1. Symptoms
  • 3.4. Diagnosis
    • 3.4.1. Blood and Urine Diagnostic Procedures
    • 3.4.2. Electrocardiography-Based Diagnostic Procedures
    • 3.4.3. Computerized Tomographic Angiography
    • 3.4.4. Electrophysiological Testing
    • 3.4.5. Electromechanical Wave Imaging
    • 3.4.6. Echocardiography
    • 3.4.7. Tilt-Taable Testing
    • 3.4.8. Diagnostic and Electrophysiological Studies
    • 3.4.9. New York Heart Association Scale
    • 3.4.10. American College of Cardiology Scale
  • 3.5. Epidemiology
    • 3.5.1. Prevalence
  • 3.6. Market Segmentation
    • 3.6.1. Electrophysiology Diagnostic Catheter
    • 3.6.2. Electrophysiology Ablation Catheter
    • 3.6.3. Electrophysiology Lab Systems
  • 3.7. Treatment Costs, Pricing, and Reimbursement
    • 3.7.1. Direct Costs
    • 3.7.2. Indirect Costs
    • 3.7.3. US Costs
    • 3.7.4. Pricing of Electrophysiology Devices and Equipment
    • 3.7.5. Reimbursement
  • 3.8. Market Characterization
    • 3.8.1. Growing Patient Population Suitable for Treatment
    • 3.8.2. Increasing Prevalence of Arrhythmia with Age
    • 3.8.3. Emergence of Remote Catheter Navigation and Ablation Technology
    • 3.8.4. Focus on the Development of "Single Shot" Devices
    • 3.8.5. Catheter Localization Aided by Novel Mapping and Visualization Techniques
    • 3.8.6. Electrophysiology Market Trends in Inorganic Growth through Consolidation
    • 3.8.7. Lack of Skilled and Experienced Electrophysiologists to Negatively Impact Procedure Volumes and Hinder Market Growth
    • 3.8.8. Awareness and Education to Drive Earlier Intervention
  • 3.9. Regulatory Issues and Recalls

4. Segment Analysis

  • 4.1. Ablation Catheters Market Dynamics
    • 4.1.1. Ablation Catheters Market Drivers
    • 4.1.2. Ablation Catheters Market Barriers
  • 4.2. Diagnostic Catheters Market Dynamics
    • 4.2.1. Diagnostic Catheters Market Drivers
    • 4.2.2. Diagnostic Catheters Market Barriers
  • 4.3. Lab Systems Market Dynamics
    • 4.3.1. Lab Systems Market Drivers
    • 4.3.2. Lab Systems Market Barriers

5. Market Outlooks by Market Segment

  • 5.1. Global Ablation Catheters Market
    • 5.1.1. Ablation Catheters Market, Global, Historic Revenue ($m), 2005-2013
    • 5.1.2. Ablation Catheters Market, Global, Forecast Revenue ($m), 2013-2020
    • 5.1.3. Diagnostic Catheters Market, Global, Historic Revenue ($m), 2005-2013
    • 5.1.4. Diagnostic Catheters Market, Global, Forecast Revenue ($m), 2013-2020
    • 5.1.5. Lab Systems Market, Global, Historic Revenue ($m), 2005-2013
    • 5.1.6. Lab Systems Market, Global, Forecast Revenue ($m), 2013-2020

6. Market Outlooks by Geography

  • 6.1. US
    • 6.1.1. Overview
    • 6.1.2. Market Analysis
  • 6.2. France
    • 6.2.1. Overview
    • 6.2.2. Market Analysis
  • 6.3. Germany
    • 6.3.1. Overview
    • 6.3.2. Market Analysis
  • 6.4. Italy
    • 6.4.1. Overview
    • 6.4.2. Market Analysis
  • 6.5. Spain
    • 6.5.1. Overview
    • 6.5.2. Market Analysis
  • 6.6. UK
    • 6.6.1. Overview
    • 6.6.2. Market Analysis
  • 6.7. Japan
    • 6.7.1. Overview
    • 6.7.2. Market Analysis
  • 6.8. China
    • 6.8.1. Overview
    • 6.8.2. Market Analysis
  • 6.9. India
    • 6.9.1. Overview
    • 6.9.2. Market Analysis
  • 6.10. Brazil
    • 6.10.1. Overview
    • 6.10.2. Market Analysis
    • 6.10.3. Market Analysis

7. Strategic Competitive Assessment

  • 7.1. Key Company Share
    • 7.1.1. Global
    • 7.1.2. US
    • 7.1.3. France
    • 7.1.4. Germany
    • 7.1.5. Italy
    • 7.1.6. Spain
    • 7.1.7. UK
    • 7.1.8. Japan
    • 7.1.9. China
    • 7.1.10. India
    • 7.1.11. Brazil

8. Current and Future Players

  • 8.1. Biosense Webster
    • 8.1.1. Overview
    • 8.1.2. Portfolio Evaluation
    • 8.1.3. Biosense Webster SWOT Analysis
    • 8.2. Biotronik
      • 8.2.1. Overview
      • 8.2.2. Portfolio Evaluation
      • 8.2.3. Biotronik SWOT Analysis
    • 8.3. Boston Scientific
      • 8.3.1. Overview
      • 8.3.2. Boston Scientific Acquires Bard EP and Rhythmia Medical
      • 8.3.3. Portfolio Evaluation
      • 8.3.4. Boston Scientific SWOT Analysis
    • 8.4. CardioFocus
      • 8.4.1. Overview
      • 8.4.2. Portfolio Evaluation
      • 8.4.3. Company SWOT Analysis
    • 8.5. CardioInsight
      • 8.5.1. Overview
      • 8.5.2. Portfolio Evaluation
      • 8.5.3. CardioInsight SWOT Analysis
    • 8.6. Hansen Medical
      • 8.6.1. Overview
      • 8.6.2. Portfolio Evaluation
      • 8.6.3. Company SWOT Analysis
    • 8.7. Imricor
      • 8.7.1. Overview
      • 8.7.2. Portfolio Evaluation
      • 8.7.3. Company SWOT Analysis
    • 8.8. Japan Lifeline
      • 8.8.1. Overview
      • 8.8.2. Portfolio Evaluation
      • 8.8.3. Company SWOT Analysis
    • 8.9. Magnetecs Corporation
      • 8.9.1. Overview
      • 8.9.2. Portfolio Evaluation
      • 8.9.3. Company SWOT Analysis
    • 8.10. Medtronic
      • 8.10.1. Overview
      • 8.10.2. Portfolio Evaluation
      • 8.10.3. Company SWOT Analysis
    • 8.11. MicroPort Scientific Company
      • 8.11.1. Overview
      • 8.11.2. Portfolio Evaluation
      • 8.11.3. MicroPort Scientific SWOT Analysis
    • 8.12. St. Jude Medical
      • 8.12.1. Overview
      • 8.12.2. Portfolio Evaluation
      • 8.12.3. Company SWOT Analysis
    • 8.13. Stereotaxis
      • 8.13.1. Overview
      • 8.13.2. Portfolio Evaluation
      • 8.13.3. Commercial Positioning
      • 8.13.4. Company SWOT Analysis
    • 8.14. Stryker Sustainability Solutions
      • 8.14.1. Overview
      • 8.14.2. Portfolio Evaluation
      • 8.14.3. Company SWOT Analysis
    • 8.15. Topera Medical
      • 8.15.1. Overview
      • 8.15.2. Portfolio Evaluation
      • 8.15.3. Company SWOT Analysis

9. Pipeline Product Assessment

  • 9.1. Pipeline Assessment by Development Stage
  • 9.2. Segment Analysis of Pipeline Products
    • 9.2.1. Ablation Catheter Pipeline Products
    • 9.2.2. Diagnostic Catheter Pipeline Products
  • 9.3. Lab Systems
    • 9.3.1. Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare)
    • 9.3.2. ClearTrace System (MRI Interventions)
    • 9.3.3. Robotic Catheter Guidance Lab System (North Carolina State University)
    • 9.3.4. Catheter Guidance Lab System (SCR)

10. Strategic Deals Analysis

  • 10.1. Key Acquisitions
    • 10.1.1. Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m
    • 10.1.2. St. Jude Medical Acquires Endosense for $161m
    • 10.1.3. Boston Scientific Acquires Rhythmia Medical for $265m
  • 10.2. Key Partnerships
    • 10.2.1. Philips and Biosense Webster Technology Integration Agreement
    • 10.2.2. Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare
    • 10.2.3. Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market

11. Appendix

  • 11.1. Bibliography
  • 11.2. Abbreviations
  • 11.3. Report Methodology
    • 11.3.1. Overview
    • 11.3.2. Coverage
    • 11.3.3. Secondary Research
    • 11.3.4. Forecasting Methodology
    • 11.3.5. Primary Research - Key Opinion Leader Interviews
    • 11.3.6. Expert Panel Validation
  • 11.4. Physicians Included in this Study
  • 11.5. About the Authors
    • 11.5.1. Analysts
    • 11.5.2. Global Head of Healthcare
  • 11.6. About MediPoint
  • 11.7. About GlobalData
  • 11.8. Disclaimer

List of Tables

  • Table 1: New York Heart Association Scale
  • Table 2: American College of Cardiology Scale
  • Table 3: Prevalent Cases of Congestive Heart Failure, Nine Major Markets, Ages ≥45 Years, Men and Women (N), 2012-2019
  • Table 4: Atrial Fibrillation Treatment Goals
  • Table 5: Reasons for Lack of Consensus on Site for Ablation
  • Table 6: Techniques for Treatment of Persistent and Permanent Atrial Fibrillation
  • Table 7: Types of Atrial Fibrillation based of Triggers
  • Table 8: Characteristics of Catheter Ablation by Arrhythmia Type (%)
  • Table 9: Rates of Occurrence of Major Complications with Catheter Ablation (%), 2003-2006
  • Table 10: Catheter Ablation Success for the Treatment of Atrial Fibrillation (%), Global, 1995-2002 & 2003-2006
  • Table 11: Catheter Ablation Success by Arrhythmia Type (%), 2009
  • Table 12: Classes of Recommendations
  • Table 13: Level of Evidence
  • Table 14: Estimation of Total Incremental Health Care Costs in Patients with Atrial Fibrillation ($), US, 2008
  • Table 15: Complications Associated with Atrial Fibrillation and Their Incremental Medicare Costs, US, 2008
  • Table 16: Average Selling Price of Electrophysiology Products by Type, Global, 2013
  • Table 17: Percentage of Population Age 65 and Older, by Country, 2010-2015
  • Table 18: Overview of the Applications, Benefits, Limitations, and Future Directions of Remote Navigation Systems in Electrophysiology
  • Table 19: Key Acquisitions in the Electrophysiology Devices Market
  • Table 20: Advantages and Disadvantages of Various Energy Sources Used for Catheter Ablation
  • Table 21: Experimental Theories of How Atrial Fibrillation Perpetuates
  • Table 22: Antiarrhythmic Drug Classification by Mode of Action
  • Table 23: Major Complications Associated with Catheter Ablation
  • Table 24: Complications Associated with Catheter Ablation
  • Table 25: Recently Approved and Investigational Antiarrhythmic Drugs Under Development
  • Table 26: Ablation Catheters Market, Global, Historic Revenue ($m), 2005-2013
  • Table 27: Ablation Catheters Market, Global, Forecast Revenue ($m), 2013-2020
  • Table 28: Diagnostic Catheters Market, Global, Historic Revenue ($m), 2005-2013
  • Table 29: Diagnostic Catheters Market, Global, Forecast Revenue ($m), 2013-2020
  • Table 30: Lab Systems Market, Global, Historic Revenue ($m), 2005-2013
  • Table 31: Lab Systems Market, Global, Forecast Revenue ($m), 2013-2020
  • Table 32: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), US, 2013
  • Table 33: Ablation Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Table 34: Ablation Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Table 35: Diagnostic Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Table 36: Diagnostic Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Table 37: Lab Systems Market, US, Historic Revenue ($m), 2005-2013
  • Table 38: Lab Systems Market, US, Forecast Revenue ($m), 2013-2020
  • Table 39: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), France, 2013
  • Table 40: Ablation Catheters Market, France, Historic Revenue ($m), 2005-2013
  • Table 41: Ablation Catheters Market, France, Forecast Revenue ($m), 2013-2020
  • Table 42: Diagnostic Catheters Market, France, Historic Revenue ($m), 2005-2013
  • Table 43: Diagnostic Catheters Market, France, Forecast Revenue ($m), 2013-2020
  • Table 44: Lab Systems Market, France, Historic Revenue ($m), 2005-2013
  • Table 45: Lab Systems Market, France, Forecast Revenue ($m), 2013-2020
  • Table 46: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Germany, 2013
  • Table 47: Ablation Catheters Market, Germany, Historic Revenue ($m), 2005-2013
  • Table 48: Ablation Catheters Market, Germany, Forecast Revenue ($m), 2013-2020
  • Table 49: Diagnostic Catheters Market, Germany, Historic Revenue ($m), 2005-2013
  • Table 50: Diagnostic Catheters Market, Germany, Forecast Revenue ($m), 2013-2020
  • Table 51: Lab Systems Market, Germany, Historic Revenue ($m), 2005-2013
  • Table 52: Lab Systems Market, Germany, Forecast Revenue ($m), 2013-2020
  • Table 53: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Italy, 2013
  • Table 54: Ablation Catheters Market, Italy, Historic Revenue ($m), 2005-2013
  • Table 55: Ablation Catheters Market, Italy, Forecast Revenue ($m), 2013-2020
  • Table 56: Diagnostic Catheters Market, Italy, Historic Revenue ($m), 2005-2013
  • Table 57: Diagnostic Catheters Market, Italy, Forecast Revenue ($m), 2013-2020
  • Table 58: Lab Systems Market, Italy, Historic Revenue ($m), 2005-2013
  • Table 59: Lab Systems Market, Italy, Forecast Revenue ($m), 2013-2020
  • Table 60: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Spain, 2013
  • Table 61: Ablation Catheters Market, Spain, Historic Revenue ($m), 2005-2013
  • Table 62: Ablation Catheters Market, Spain, Forecast Revenue ($m), 2013-2020
  • Table 63: Diagnostic Catheters Market, Spain, Historic Revenue ($m), 2005-2013
  • Table 64: Diagnostic Catheters Market, Spain, Forecast Revenue ($m), 2013-2020
  • Table 65: Lab Systems Market, Spain, Historic Revenue ($m), 2005-2013
  • Table 66: Lab Systems Market, Spain, Forecast Revenue ($m), 2013-2020
  • Table 67: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), UK, 2013
  • Table 68: Ablation Catheters Market, UK, Historic Revenue ($m), 2005-2013
  • Table 69: Ablation Catheters Market, UK, Forecast Revenue ($m), 2013-2020
  • Table 70: Diagnostic Catheters Market, UK, Historic Revenue ($m), 2005-2013
  • Table 71: Diagnostic Catheters Market, UK, Forecast Revenue ($m), 2013-2020
  • Table 72: Lab Systems Market, UK, Historic Revenue ($m), 2005-2013
  • Table 73: Lab Systems Market, UK, Forecast Revenue ($m), 2013-2020
  • Table 74: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Japan, 2013
  • Table 75: Ablation Catheters Market, Japan, Historic Revenue ($m), 2005-2013
  • Table 76: Ablation Catheters Market, Japan, Forecast Revenue ($m), 2013-2020
  • Table 77: Diagnostic Catheters Market, Japan, Historic Revenue ($m), 2005-2013
  • Table 78: Diagnostic Catheters Market, Japan, Forecast Revenue ($m), 2013-2020
  • Table 79: Lab Systems Market, Japan, Historic Revenue ($m), 2005-2013
  • Table 80: Lab Systems Market, Japan, Forecast Revenue ($m), 2013-2020
  • Table 81: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), China, 2013
  • Table 82: Ablation Catheters Market, China, Historic Revenue ($m), 2005-2013
  • Table 83: Ablation Catheters Market, China, Forecast Revenue ($m), 2013-2020
  • Table 84: Diagnostic Catheters Market, China, Historic Revenue ($m), 2005-2013
  • Table 85: Diagnostic Catheters Market, China, Forecast Revenue ($m), 2013-2020
  • Table 86: Lab Systems Market, China, Historic Revenue ($m), 2005-2013
  • Table 87: Lab Systems Market, China, Forecast Revenue ($m), 2013-2020
  • Table 88: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), India, 2013
  • Table 89: Ablation Catheters Market, India, Historic Revenue ($m), 2005-2013
  • Table 90: Ablation Catheters Market, India, Forecast Revenue ($m), 2013-2020
  • Table 91: Diagnostic Catheters Market, India, Historic Revenue ($m), 2005-2013
  • Table 92: Diagnostic Catheters Market, India, Forecast Revenue ($m), 2013-2020
  • Table 93: Lab Systems Market, India, Historic Revenue ($m), 2005-2013
  • Table 94: Lab Systems Market, India, Forecast Revenue ($m), 2013-2020
  • Table 95: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Brazil, 2013
  • Table 96: Ablation Catheters Market, Brazil, Historic Revenue ($m), 2005-2013
  • Table 97: Ablation Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020
  • Table 98: Diagnostic Catheters Market, Brazil, Historic Revenue ($m), 2005-2013
  • Table 99: Diagnostic Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020
  • Table 100: Lab Systems Market, Brazil, Historic Revenue ($m), 2005-2013
  • Table 101: Lab Systems Market, Brazil, Forecast Revenue ($m), 2013-2020
  • Table 102: Company Share, US, Total Electrophysiology Market Revenue (%), 2012
  • Table 103: Company Share, France, Total Electrophysiology Market Revenue (%), 2012
  • Table 104: Company Share, Germany, Total Electrophysiology Market Revenue (%), 2012
  • Table 105: Company Share, Italy, Total Electrophysiology Market Revenue (%), 2012
  • Table 106: Company Share, Spain, Total Electrophysiology Market Revenue (%), 2012
  • Table 107: Company Share, UK, Total Electrophysiology Market Revenue (%), 2012
  • Table 108: Company Share, Japan, Total Electrophysiology Market Revenue (%), 2012
  • Table 109: Company Share, China, Total Electrophysiology Market Revenue (%), 2012
  • Table 110: Company Share, India, Total Electrophysiology Market Revenue (%), 2012
  • Table 111: Company Share, Brazil, Total Electrophysiology Market Revenue (%), 2012
  • Table 112: Company Profile - Biosense Webster
  • Table 113: Biosense Webster, Electrophysiology Devices Portfolio
  • Table 114: SWOT Analysis - Biosense Webster
  • Table 115: Company Profile - Biotronik
  • Table 116: Biotronik, Electrophysiology Devices Portfolio
  • Table 117: SWOT Analysis - Biotronik
  • Table 118: Company Profile - Boston Scientific
  • Table 119: Boston Scientific, Electrophysiology Devices Portfolio
  • Table 120: SWOT Analysis - Boston Scientific
  • Table 121: Company Profile - CardioFocus
  • Table 122: CardioFocus, Electrophysiology Devices Portfolio
  • Table 123: SWOT Analysis - CardioFocus
  • Table 124: Company Profile - CardioInsight
  • Table 125: CardioInsight, Electrophysiology Devices Portfolio
  • Table 126: SWOT Analysis - CardioInsight
  • Table 127: Company Profile - Hansen Medical
  • Table 128: Hansen Medical, Electrophysiology Devices Portfolio
  • Table 129: SWOT Analysis - Hansen Medical
  • Table 130: Company Profile - Imricor
  • Table 131: SWOT Analysis - Imricor
  • Table 132: Company Profile - Japan Lifeline
  • Table 133: Japan Lifeline, Electrophysiology Devices Portfolio
  • Table 134: SWOT Analysis - Japan Lifeline
  • Table 135: Company Profile - Magnetecs Corporation
  • Table 136: Magnetecs Corporation, Electrophysiology Devices Portfolio
  • Table 137: SWOT Analysis - Magnetecs Corporation
  • Table 138: Company Profile - Medtronic
  • Table 139: Medtronic, Electrophysiology Devices Portfolio, 2013
  • Table 140: SWOT Analysis - Medtronic
  • Table 141: Company Profile - MicroPort Scientific Company
  • Table 142: MicroPort Scientific, Electrophysiology Devices Portfolio
  • Table 143: SWOT Analysis - MicroPort Scientific
  • Table 144: Company Profile - St. Jude Medical
  • Table 145: St. Jude Medical, Electrophysiology Devices Portfolio
  • Table 146: SWOT Analysis - St. Jude Medical
  • Table 147: Company Profile - Stereotaxis
  • Table 148: Stereotaxis, Electrophysiology Devices Portfolio
  • Table 149: SWOT Analysis - Stereotaxis
  • Table 150: Company Profile - Stryker Sustainability Solutions
  • Table 151: Stryker Sustainability Solutions, Electrophysiology Devices Portfolio
  • Table 152: SWOT Analysis - Stryker Sustainability Solutions
  • Table 153: Company Profile - Topera Medical
  • Table 154: Topera Medical, Electrophysiology Devices Portfolio, 2013
  • Table 155: SWOT Analysis - Topera Medical
  • Table 156: Ablation Catheter Pipeline Products
  • Table 157: Diagnostic Catheter Pipeline Products
  • Table 158: Lab Systems Pipeline Products
  • Table 159: Catheter Ablation Device, Product Status
  • Table 160: Ablation Catheter Device - Transcutaneous Monitoring to Avoid Hypercapnea during Complex Catheter Ablations
  • Table 161: Apama Medical Ablation Catheter, Product Status
  • Table 162: Cooled Tip Catheter, Product Status
  • Table 163: MaPP-CS, Product Status
  • Table 164: ROF-AC, Product Status
  • Table 165: ROF-AS, Product Status
  • Table 166: Vision MR Ablation Catheter, Product Status
  • Table 167: Voyager Irrigated RFA Catheter, Product Status
  • Table 168: Navigation and Ablation Catheter, Product Status
  • Table 169: Hot Balloon Catheter, Product Status
  • Table 170: Lesion Assessment Device, Product Status
  • Table 171: Horizon MR Recording System, Product Status
  • Table 172: Integrated X-Ray and Robotic Catheter System, Product Status
  • Table 173: ClearTrace System, Product Status
  • Table 174: Robotic Catheter Guidance Lab System, Product Status
  • Table 175: Catheter Guidance Lab System, Product Status
  • Table 176: Key Acquisitions in the Electrophysiology Market

List of Figures

  • Figure 1: Types of Arrhythmia
  • Figure 2: Pulmonary Vein Ablation Procedure
  • Figure 3: Antiarrhythmic Drugs and/or Ablation for Rhythm Control in Atrial Fibrillation
  • Figure 4: Cost Comparison of Ablation versus Antiarrhythmic Drug Therapy, 2009
  • Figure 5: Breakdown of National Incremental Costs in patients with Atrial Fibrillation
  • Figure 6: Ablation Catheters Market, Global, Historic Revenue ($m), 2005-2013
  • Figure 7: Ablation Catheters Market, Global, Forecast Revenue ($m), 2013-2020
  • Figure 8: Diagnostic Catheters Market, Global, Historic Revenue ($m), 2005-2013
  • Figure 9: Diagnostic Catheters Market, Global, Forecast Revenue ($m), 2013-2020
  • Figure 10: Lab Systems Market, Global, Historic Revenue ($m), 2005-2013
  • Figure 11: Lab Systems Market, Global, Forecast Revenue ($m), 2013-2020
  • Figure 12: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), US, 2013
  • Figure 13: Ablation Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Figure 14: Ablation Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Figure 15: Diagnostic Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Figure 16: Diagnostic Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Figure 17: Lab Systems Market, US, Historic Revenue ($m), 2005-2013
  • Figure 18: Lab Systems Market, US, Forecast Revenue ($m), 2013-2020
  • Figure 19: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), France, 2013
  • Figure 20: Ablation Catheters Market, France, Historic Revenue ($m), 2005-2013
  • Figure 21: Ablation Catheters Market, France, Forecast Revenue ($m), 2013-2020
  • Figure 22: Diagnostic Catheters Market, France, Historic Revenue ($m), 2005-2013
  • Figure 23: Diagnostic Catheters Market, France, Forecast Revenue ($m), 2013-2020
  • Figure 24: Lab Systems Market, France, Historic Revenue ($m), 2005-2013
  • Figure 25: Lab Systems Market, France, Forecast Revenue ($m), 2013-2020
  • Figure 26: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Germany, 2013
  • Figure 27: Ablation Catheters Market, Germany, Historic Revenue ($m), 2005-2013
  • Figure 28: Ablation Catheters Market, Germany, Forecast Revenue ($m), 2013-2020
  • Figure 29: Diagnostic Catheters Market, Germany, Historic Revenue ($m), 2005-2013
  • Figure 30: Diagnostic Catheters Market, Germany, Forecast Revenue ($m), 2013-2020
  • Figure 31: Lab Systems Market, Germany, Historic Revenue ($m), 2005-2013
  • Figure 32: Lab Systems Market, Germany, Forecast Revenue ($m), 2013-2020
  • Figure 33: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Italy, 2013
  • Figure 34: Ablation Catheters Market, Italy, Historic Revenue ($m), 2005-2013
  • Figure 35: Ablation Catheters Market, Italy, Forecast Revenue ($m), 2013-2020
  • Figure 36: Diagnostic Catheters Market, Italy, Historic Revenue ($m), 2005-2013
  • Figure 37: Diagnostic Catheters Market, Italy, Forecast Revenue ($m), 2013-2020
  • Figure 38: Lab Systems Market, Italy, Historic Revenue ($m), 2005-2013
  • Figure 39: Lab Systems Market, Italy, Forecast Revenue ($m), 2013-2020
  • Figure 40: Ablating Centers in Spain, 2001-2011
  • Figure 41: Ablation Procedures by Hospital Size and Type, 2012
  • Figure 42: Ablation Procedures by Target Substrate
  • Figure 43: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Spain, 2013
  • Figure 44: Ablation Catheters Market, Spain, Historic Revenue ($m), 2005-2013
  • Figure 45: Ablation Catheters Market, Spain, Forecast Revenue ($m), 2013-2020
  • Figure 46: Diagnostic Catheters Market, Spain, Historic Revenue ($m), 2005-2013
  • Figure 47: Diagnostic Catheters Market, Spain, Forecast Revenue ($m), 2013-2020
  • Figure 48: Lab Systems Market, Spain, Historic Revenue ($m), 2005-2013
  • Figure 49: Lab Systems Market, Spain, Forecast Revenue ($m), 2013-2020
  • Figure 50: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), UK, 2013
  • Figure 51: Ablation Catheters Market, UK, Historic Revenue ($m), 2005-2013
  • Figure 52: Ablation Catheters Market, UK, Forecast Revenue ($m), 2013-2020
  • Figure 53: Diagnostic Catheters Market, UK, Historic Revenue ($m), 2005-2013
  • Figure 54: Diagnostic Catheters Market, UK, Forecast Revenue ($m), 2013-2020
  • Figure 55: Lab Systems Market, UK, Historic Revenue ($m), 2005-2013
  • Figure 56: Lab Systems Market, UK, Forecast Revenue ($m), 2013-2020
  • Figure 57: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Japan, 2013
  • Figure 58: Ablation Catheters Market, Japan, Historic Revenue ($m), 2005-2013
  • Figure 59: Ablation Catheters Market, Japan, Forecast Revenue ($m), 2013-2020
  • Figure 60: Diagnostic Catheters Market, Japan, Historic Revenue ($m), 2005-2013
  • Figure 61: Diagnostic Catheters Market, Japan, Forecast Revenue ($m), 2013-2020
  • Figure 62: Lab Systems Market, Japan, Historic Revenue ($m), 2005-2013
  • Figure 63: Lab Systems Market, Japan, Forecast Revenue ($m), 2013-2020
  • Figure 64: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), China, 2013
  • Figure 65: Ablation Catheters Market, China, Historic Revenue ($m), 2005-2013
  • Figure 66: Ablation Catheters Market, China, Forecast Revenue ($m), 2013-2020
  • Figure 67: Diagnostic Catheters Market, China, Historic Revenue ($m), 2005-2013
  • Figure 68: Diagnostic Catheters Market, China, Forecast Revenue ($m), 2013-2020
  • Figure 69: Lab Systems Market, China, Historic Revenue ($m), 2005-2013
  • Figure 70: Lab Systems Market, China, Forecast Revenue ($m), 2013-2020
  • Figure 71: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), India, 2013
  • Figure 72: Ablation Catheters Market, India, Historic Revenue ($m), 2005-2013
  • Figure 73: Ablation Catheters Market, India, Forecast Revenue ($m), 2013-2020
  • Figure 74: Diagnostic Catheters Market, India, Historic Revenue ($m), 2005-2013
  • Figure 75: Diagnostic Catheters Market, India, Forecast Revenue ($m), 2013-2020
  • Figure 76: Lab Systems Market, India, Historic Revenue ($m), 2005-2013
  • Figure 77: Lab Systems Market, India, Forecast Revenue ($m), 2013-2020
  • Figure 78: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Brazil, 2013
  • Figure 79: Ablation Catheters Market, Brazil, Historic Revenue ($m), 2005-2013
  • Figure 80: Ablation Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020
  • Figure 81: Diagnostic Catheters Market, Brazil, Historic Revenue ($m), 2005-2013
  • Figure 82: Diagnostic Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020
  • Figure 83: Lab Systems Market, Brazil, Historic Revenue ($m), 2005-2013
  • Figure 84: Lab Systems Market, Brazil, Forecast Revenue ($m), 2013-2020
  • Figure 85: Company Share, US, Total Electrophysiology Market Revenue (%), 2012
  • Figure 86: Company Share, France, Total Electrophysiology Market Revenue (%), 2012
  • Figure 87: Company Share, Germany, Total Electrophysiology Market Revenue (%), 2012
  • Figure 88: Company Share, Italy, Total Electrophysiology Market Revenue (%), 2012
  • Figure 89: Company Share, Spain, Total Electrophysiology Market Revenue (%), 2012
  • Figure 90: Company Share, UK, Total Electrophysiology Market Revenue (%), 2012
  • Figure 91: Company Share, Japan, Total Electrophysiology Market Revenue (%), 2012
  • Figure 92: Company Share, China, Total Electrophysiology Market Revenue (%), 2012
  • Figure 93: Company Share, India, Total Electrophysiology Market Revenue (%), 2012
  • Figure 94: Company Share, Brazil, Total Electrophysiology Market Revenue (%), 2012
Back to Top